Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT05020236

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Clovis Community Medical Center Clovis, California, United States
  • Community Regional Medical Center Fresno, California, United States
  • UCHealth Poudre Valley Hospital Fort Collins, Colorado, United States
  • UCHealth Greeley Hospital Greeley, Colorado, United States
View all 237 locations
View Trial Details
Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

NCT06846671

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • St Bernards Medical Center Jonesboro, Arkansas, United States
  • UCLA Department of Medicine Hematologyoncology Los Angeles, California, United States
  • Pih Health Whittier Hospital Whittier, California, United States
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
View all 130 locations
View Trial Details
Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT04973605

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Irvine Lennar Irvine, California, United States
  • University of Miami Miami, Florida, United States
View all 82 locations
View Trial Details
Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

NCT07439653

Conditions
Hemic and Lymphatic Diseases, Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, Immune System Diseases, +8 more
Locations
  • UCLA Santa Monica, California, United States
  • Stanford University Stanford, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Providence Medical Foundation Fullerton, California, United States
View Trial Details

Related conditions